These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25864169)

  • 41. Coarctation of the aorta: are genes relevant?
    Francis CM
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):546-56. PubMed ID: 27243623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic medicine in gastroenterology: A new approach or a new specialty?
    Roman S; Panduro A
    World J Gastroenterol; 2015 Jul; 21(27):8227-37. PubMed ID: 26217074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
    Sookoian S; Pirola CJ
    World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variants predisposing to cardiovascular disease.
    Visvikis-Siest S; Marteau JB
    Curr Opin Lipidol; 2006 Apr; 17(2):139-51. PubMed ID: 16531750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS; Donahue MP; Newby LK
    J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges and opportunities in stroke genetics.
    Malik R; Dichgans M
    Cardiovasc Res; 2018 Jul; 114(9):1226-1240. PubMed ID: 29554300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.
    Tada H; Kawashiri MA; Nohara A; Saito R; Tanaka Y; Nomura A; Konno T; Sakata K; Fujino N; Takamura T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2015 Jun; 240(2):324-9. PubMed ID: 25875382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers of cardiovascular disease: molecular basis and practical considerations.
    Vasan RS
    Circulation; 2006 May; 113(19):2335-62. PubMed ID: 16702488
    [No Abstract]   [Full Text] [Related]  

  • 49. Intrafamilial associations of cardiometabolic risk factors--results of the Ulm Birth Cohort Study.
    Brandt S; Moß A; Koenig W; Rothenbacher D; Brenner H; Wabitsch M
    Atherosclerosis; 2015 May; 240(1):174-83. PubMed ID: 25796035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The personal genome and the practice of cardiovascular medicine.
    Marian AJ
    Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):13-20. PubMed ID: 21088654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adult-onset autoinflammatory disorders: a still debated entity?
    Cantarini L; Rigante D
    Clin Exp Rheumatol; 2015; 33(2):137-40. PubMed ID: 25896471
    [No Abstract]   [Full Text] [Related]  

  • 52. [Genomic research in hypertension and cardiovascular diseases].
    Morita H; Nagai R
    Nihon Rinsho; 2009 Jun; 67(6):1095-102. PubMed ID: 19507499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic variation of platelet function and pharmacology: an update of current knowledge.
    Geisler T; Schaeffeler E; Gawaz M; Schwab M
    Thromb Haemost; 2013 Nov; 110(5):876-87. PubMed ID: 23702580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and genetic approaches to the study of cardiovascular disease.
    Hallman DM; Ellsworth DL; Boerwinkle E
    J Cardiovasc Risk; 1997; 4(5-6):325-31. PubMed ID: 9865662
    [No Abstract]   [Full Text] [Related]  

  • 55. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.
    Podgoreanu MV; Schwinn DA
    J Am Coll Cardiol; 2005 Dec; 46(11):1965-77. PubMed ID: 16325027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relevance of twin studies to cardiovascular research.
    Nance WE
    Prog Clin Biol Res; 1984; 147():325-48. PubMed ID: 6377316
    [No Abstract]   [Full Text] [Related]  

  • 57. MicroRNAs within the continuum of postgenomics biomarker discovery.
    Mayr M; Zampetaki A; Willeit P; Willeit J; Kiechl S
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):206-14. PubMed ID: 23325478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What can cardiovascular gene transfer learn from genomics: and vice versa?
    Kim TH; Skelding KA; Nabel EG; Simari RD
    Physiol Genomics; 2002 Dec; 11(3):179-82. PubMed ID: 12464691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heartbeat: Do common genetic variants have a role in cardiovascular disease prediction?
    Otto CM
    Heart; 2016 Oct; 102(20):1605-6. PubMed ID: 27679805
    [No Abstract]   [Full Text] [Related]  

  • 60. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.